Actavis Ordered To Pay $170M In Medicaid Fraud Suit
A Texas jury has returned a $170 million verdict against generic-drug maker Actavis Mid-Atlantic LLC for allegedly inflating its drug prices to Medicaid, a civil damages amount that Texas officials are...To view the full article, register now.
Already a subscriber? Click here to view full article